Researchers generated a single-dose, fast-acting vesicular stomatitis virus (VSV)-based vaccine derived from the licensed Ebola virus (EBOV) vaccine rVSV-ZEBOV, expressing the SARS-CoV-2 spike protein and the EBOV glycoprotein.
[mBio]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
170566
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/